French policy change to cut amnio rates
This article was originally published in Clinica
Executive Summary
In an attempt to reduce the number of amniocenteses carried out in France, and at the same time as improving the rate of detection of Trisomy 21, the Supreme Health Authority in France (HAS) has recommended that pregnant women should be offered two tests during the first three months of pregnancy: the first a measure of nuchal translucency screening during ultrasound in the third month and the second a blood test to assess the maternal markers (alpha fetoprotein). This should be accompanied by patient leaflets explaining the tests for Down's syndrome and their risks.